News FDA approves Pfizer's Besponsa in aggressive blood cancer Besponsa becomes first of its kind indicated for rare type of acute lymphoblastic leukaemia.
News Real world data essential for CAR-T therapy success Innovators will need to quantify value to bring costly drugs to market.
News Kite files CAR-T therapy in EU, ahead of Novartis rival Kite eyes possible CAR-T launch next year.
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
